December 29, 2022
Article
Editor's Page
Discovering different genetic mutations to target ... continues to add to the excitement.
December 27, 2022
Article
Speaking Out
As a part of its “Speaking Out” video series, CURE® spoke with Meryl Uranga, on behalf of KidneyCAN, about the importance of working as a team with their clinicians and getting educated before making decisions.
December 26, 2022
Article
One expert explains how the road to cancer drug development isn’t a smooth one, but progress can be made nonetheless.
December 23, 2022
Article
FDA-approved immunotherapies offer patients with metastatic or recurrent sarcomatoid RCC more treatment choices and improved outcomes.
December 20, 2022
Article
Feature
HIF-2 alpha inhibitors are transforming therapy for patients with renal cell carcinoma and von Hippel-Lindau disease.
December 13, 2022
Article
Newer drugs for kidney cancer have proven extremely effective but can cause unwanted symptoms that affect safety and quality of life.
Adjuvant Chemoradiotherapy Demonstrated Better Outcomes for Patients With Endometrial Cancer
As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis
First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer
FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer